TRXC
$0.33
Transenterix
($.01)
(3.26%)
TRXC
Earnings Whisper ®
N/A
1st Quarter March 2020
Consensus:  ($0.53)
Revenue:  $0.54 Mil
Monday
Jun 15
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when TRXC reports earnings?
Beat
Meet
Miss

Where is TRXC's stock price going from here?
Up
Flat
Down
Stock chart of TRXC
Analysts
Summary of analysts' recommendations for TRXC
Score
Grade
Pivots
Resistance
$0.40
$0.38
$0.35

$0.33

Support
$0.31
$0.29
$0.26
Tweet
Growth
Description
TransEnterix Inc. designs, develops and manufactures medical-devices. It offers SPIDER(R) Surgical System, a laparoscopic surgical platform that allows intra-abdominal triangulation procedures to be performed with articulating instruments through a single site. The company is primarily focused on the development and commercialization of SurgiBot, a patient-side minimally invasive surgical robotic system. TransEnterix Inc., formerly known as SafeStitch Medical, Inc., is based in United States.
Peers
StrykerBoston ScientificBecton, DickinsonBaxter InternationalAbbott LaboratoriesWatersTeleflex3MIntegra LifeSciences HoldingsAbiomed